Valuation: SoftOx Solutions AS

Market Cap 333M 34.75M 31M 28.88M 26.28M 49.49M 3.35B 49.86M 349M 136M 1.71B 130M 128M 5.49B P/E 2024
-0.64x
P/E 2025 -19.4x
Enterprise Value 313M 32.68M 29.16M 27.16M 24.72M 46.55M 3.15B 46.9M 328M 128M 1.61B 123M 120M 5.16B EV / Sales 2024
2.12x
EV / Sales 2025 12.2x
Free-Float
62.45%
Yield 2024 *
-
Yield 2025 -

Last Transcript: SoftOx Solutions AS

Manager TitleAgeSince
Chief Executive Officer - 01/09/2024
Director of Finance/CFO - -
Corporate Officer/Principal - 01/01/2026
Director TitleAgeSince
Director/Board Member - -
Chairman - -
Director/Board Member 58 27/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%+3.33% - - 34.75M
+4.16%+3.42%+49.37%+94.17% 74.31B
+1.99%-2.43%+21.77%+77.03% 56.95B
+1.72%+0.38%+5.20%+36.64% 48.3B
+0.50%+2.94%+344.62%+722.17% 44.51B
+3.05%-1.80%+28.78%+34.51% 43.8B
+1.00%-1.46%+5.17%+111.90% 41.12B
-0.54%+2.41%+9.31%+58.85% 31.07B
+4.60%+8.32%+37.98%+32.61% 28.97B
+0.76%-1.45%-7.44%-11.12% 24.53B
Average +1.48%-0.15%+54.97%+128.53% 43.73B
Weighted average by Cap. +2.11%-0.46%+58.90%+136.99%

Financials

2024 2025
Net sales 7.91M 826K 737K 686K 625K 1.18M 79.52M 1.18M 8.29M 3.23M 40.59M 3.1M 3.03M 130M 15.58M 1.63M 1.45M 1.35M 1.23M 2.32M 157M 2.33M 16.33M 6.35M 79.92M 6.1M 5.97M 257M
Net income -42.94M -4.48M -4M -3.72M -3.39M -6.38M -432M -6.43M -45M -17.51M -220M -16.82M -16.46M -708M -10.81M -1.13M -1.01M -938K -853K -1.61M -109M -1.62M -11.33M -4.41M -55.46M -4.24M -4.14M -178M
Net Debt -10.51M -1.1M -979K -912K -830K -1.56M -106M -1.57M -11.02M -4.29M -53.92M -4.12M -4.03M -173M -19.79M -2.07M -1.84M -1.72M -1.56M -2.94M -199M -2.96M -20.74M -8.07M -102M -7.75M -7.59M -326M
Logo SoftOx Solutions AS
SoftOx Solutions AS is a Norway-based medtech and biotech company, that develops products to help fight infections from viruses, biofilm resistance and antimicrobial resistance. It is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOx’s product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The Company has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
Employees
-